(Q58895670)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17135263%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

title

A role for protein misfolding in immunogenicity of biopharmaceuticals (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17135263%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17135263%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

4

Wim Jiskoot

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17135263%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

author name string

Suzanne Hermeling

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17135263%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Barend Bouma

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17135263%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Martijn F B G Gebbink

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17135263%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

language of work or name

English

0 references

publication date

29 November 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17135263%20AND%20SRC:MED&resulttype=core&format=json

Journal of Biological Chemistry

22 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17135263%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

volume

282

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17135263%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17135263%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

page(s)

2229-2236

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17135263%20AND%20SRC:MED&resulttype=core&format=json

Recombinant protein therapeutics--success rates, market trends and values to 2010.

22 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605984200

Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605984200

Bioequivalence and the immunogenicity of biopharmaceuticals

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605984200

Immunogenicity of therapeutic proteins: clinical implications and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605984200

Antibodies against erythropoietin and other protein-based therapeutics: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605984200

Immune responses to therapeutic proteins in humans--clinical significance, assessment and prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605984200

Minimizing the immunogenicity of protein therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605984200

Antibody-mediated side effects of recombinant proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605984200

Influence of the type of factor VIII concentrate on the incidence of factor VIII inhibitors in previously untreated patients with severe hemophilia A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605984200

Transmembrane signalling in human monocyte/mesangial cell co-cultures: role of cytosolic Ca(2+).

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605984200

Environmental and genetic factors influencing inhibitor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605984200

Protein aggregation and its inhibition in biopharmaceutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605984200

Quantification and significance of protein oxidation in biological samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605984200

Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605984200

Glycation induces formation of amyloid cross-beta structure in albumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605984200

Structural basis of the cofactor function of denatured albumin in plasminogen activation by tissue-type plasminogen activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605984200

Oxidation of low-density lipoproteins induces amyloid-like structures that are recognized by macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605984200

Chemical modification of insulin in amyloid fibrils

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605984200

Surface-catalyzed amyloid fibril formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605984200

Formation of amyloid fibers triggered by phosphatidylserine-containing membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605984200

Lyophilization and development of solid protein pharmaceuticals

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605984200

Sonication of proteins causes formation of aggregates that resemble amyloid

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605984200

Protein drug stability: a formulation challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605984200

Autoimmune responses to amyloid structures of Abeta(25-35) peptide and human lysozyme in the serum of patients with progressive Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605984200

CD40 signaling regulates innate and adaptive activation of microglia in response to amyloid beta-peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605984200

Antibody Response to Aggregated Human Interferon Alpha2b in Wild-type and Transgenic Immune Tolerant Mice Depends on Type and Level of Aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605984200

CD36 Is Differentially Expressed by CD8+ Splenic Dendritic Cells But Is Not Required for Cross-Presentation In Vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605984200

Role of amyloid type cross beta-structure in the formation of soluble aggregate and gel in heat-induced ovalbumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605984200

The increased incidence of pure red cell aplasia with an Eprex formulation in uncoated rubber stopper syringes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605984200

Advanced glycosylation end products might promote atherosclerosis through inducing the immune maturation of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605984200

Effects of sucrose on rFVIIa aggregation and methionine oxidation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605984200

21 January 2018

Identifiers

DOI

10.1074/JBC.M605984200

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17135263%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

1 reference